Skip to main content

Want a detailed portfolio tracker?

OverviewPerformanceMetricsFinancialsETFsIndustryCorrelations

Performance analysis of Drugs Made In America Acquisition (DMAA)

Annual Return

Since Feb 25, 2025, DMAA has had an average annual return of +5.11%, underperforming the benchmark SPY, which returned +22.06% annual.

20262025
+2.28%+4.16%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2026+0.54%+0.29%+0.19%+0.48%+0.77%+0%+2.28%
2025+0.10%+0.50%+0.71%+0.39%+0.69%+0.68%-0.16%+0.16%+0.39%+0.19%+0.43%+4.16%

Drawdown analysis of Drugs Made In America Acquisition (DMAA)

The maximum drawdown for the DMAA was -0.50%, occurring on Mar 13, 2025. Recovery took 15 trading sessions.

DepthStartTo BottomBottomTo RecoverEndTotal
-0.50%Mar 12, 20251Mar 13, 202515Apr 3, 202516
-0.48%Aug 11, 20251Aug 12, 202515Sep 3, 202516
-0.48%Sep 9, 20252Sep 11, 20259Sep 24, 202511
-0.48%Sep 24, 20255Oct 1, 202516Oct 23, 202521
-0.40%Apr 3, 20251Apr 4, 202515Apr 28, 202516
-0.38%Mar 17, 20261Mar 18, 20262Mar 20, 20263
-0.38%Mar 20, 20261Mar 23, 202616Apr 15, 202617
-0.33%Apr 27, 20263Apr 30, 20261May 1, 20264
-0.29%Jul 8, 20251Jul 9, 20258Jul 21, 20259
-0.29%Sep 3, 20251Sep 4, 20253Sep 9, 20254
-0.29%Jan 22, 20261Jan 23, 202611Feb 9, 202612
-0.20%Nov 21, 20252Nov 25, 20259Dec 9, 202511
-0.20%Mar 7, 20252Mar 11, 20251Mar 12, 20253
-0.20%May 6, 20269May 19, 20264May 26, 202613
-0.19%Feb 9, 20261Feb 10, 20268Feb 23, 20269
-0.19%Feb 26, 20261Feb 27, 20264Mar 5, 20265
-0.19%Mar 5, 20261Mar 6, 20267Mar 17, 20268
-0.15%Jul 23, 202512Aug 8, 20251Aug 11, 202513
-0.12%Nov 4, 20252Nov 6, 20253Nov 11, 20255
-0.11%Apr 29, 20253May 2, 20251May 5, 20254
-0.10%Feb 26, 20251Feb 27, 20254Mar 5, 20255
-0.10%May 5, 20251May 6, 20255May 13, 20256
-0.10%May 19, 20252May 21, 20254May 28, 20256
-0.10%May 28, 20252May 30, 20251Jun 2, 20253
-0.10%Jun 4, 20251Jun 5, 20253Jun 10, 20254